Frontiers in Cellular and Infection Microbiology (Sep 2021)

Pathogen Metagenomics Reveals Distinct Lung Microbiota Signatures Between Bacteriologically Confirmed and Negative Tuberculosis Patients

  • Li Ding,
  • Li Ding,
  • Li Ding,
  • Yanmin Liu,
  • Yanmin Liu,
  • Yanmin Liu,
  • Xiaorong Wu,
  • Xiaorong Wu,
  • Xiaorong Wu,
  • Minhao Wu,
  • Minhao Wu,
  • Minhao Wu,
  • Xiaoqing Luo,
  • Xiaoqing Luo,
  • Hui Ouyang,
  • Hui Ouyang,
  • Jinyu Xia,
  • Jinyu Xia,
  • Jinyu Xia,
  • Xi Liu,
  • Xi Liu,
  • Xi Liu,
  • Tao Ding,
  • Tao Ding,
  • Tao Ding

DOI
https://doi.org/10.3389/fcimb.2021.708827
Journal volume & issue
Vol. 11

Abstract

Read online

Understanding the dynamics of lung microbiota in tuberculosis patients, especially those who cannot be confirmed bacteriologically in clinical practice, is imperative for accurate diagnosis and effective treatment. This study aims to characterize the distinct lung microbial features between bacteriologically confirmed and negative tuberculosis patients to understand the influence of microbiota on tuberculosis patients. We collected specimens of bronchoalveolar lavage fluid from 123 tuberculosis patients. Samples were subjected to metagenomic next-generation sequencing to reveal the lung microbial signatures. By combining conventional bacterial detection and metagenomic sequencing, 101/123 (82%) tuberculosis patients were bacteriologically confirmed. In addition to Mycobacterium tuberculosis, Staphylococcus aureus, Kluyveromyces lactis, and Pyricularia pennisetigena were also enriched in the bacteriological confirmation group. In contrast, Haemophilus parainfluenzae was enriched in the bacteriologically negative group. Besides, microbial interaction exhibits a different state between bacteriologically confirmed and negative tuberculosis patients. Mycobacterium tuberculosis was confirmed correlated with clinical characteristics such as albumin and chest cavities. Our study comprehensively demonstrates the correlation between unique features of lung microbial dynamics and the clinical characteristics of tuberculosis patients, suggesting the importance of studying the pulmonary microbiome in tuberculosis disease and providing new insights for future precision diagnosis and treatment.

Keywords